Search results
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Michael Shepard, MD specializes in orthopaedic surgery. He renders the most comprehensive care for knee, elbow and shoulder injuries. Dr. Shepard uses the latest medical technology with the state of art medical facility to provide his patients the best possible outcome.
22 hours ago · Michael Shepard is an internationally recognized financial crime risk management executive with 37 years of experience. Over his distinguished career, he was a principal at Deloitte for 18 years ...
H. Michael Shepard is one of the three scientists who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein and treats breast cancer. He received the 2019 Lasker~DeBakey Clinical Medical Research Award with Dennis J. Slamon and Axel Ullrich.
Dr. H. Michael Shepard is a global, leading authority on cancer research and therapeutics. He is best known for his invention of "Herceptin"/Trastuzumab, which has remained one of the most profitable platforms for Roche (>$7B USD).
Nov 30, 2021 · Dr. Michael Shepard is the President and CSO of Enosi Life Sciences, a company developing biologics for autoimmune and cancer diseases. He won the 2019 Lasker-DeBakey Award for inventing Herceptin, a targeted antibody therapy for breast cancer.
